In silico and experimental studies of bovine serum albumin-encapsulated carbenoxolone nanoparticles with reduced cytotoxicity
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 202, 111670
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Agricultural Research
This publication has 44 references indexed in Scilit:
- Controlled drug release from pharmaceutical nanocarriersChemical Engineering Science, 2015
- Cytotoxicity of BSA-Stabilized Gold Nanoclusters: In Vitro and In Vivo StudySmall, 2015
- Spectroscopic analysis on structure–affinity relationship in the interactions of different oleanane‐type triterpenoids with bovine serum albuminLuminescence, 2014
- Synthesis and antiviral activities of spacer-linked 1-thioglucuronide analogues of glycyrrhizinBeilstein Journal of Organic Chemistry, 2012
- Evaluation of drug–human serum albumin binding interactions with support vector machine aided online automated dockingBioinformatics, 2011
- Connexon‐mediated cell adhesion drives microtissue self‐assemblyThe FASEB Journal, 2010
- Inhaled Carbenoxolone Prevents Allergic Airway Inflammation and Airway Hyperreactivity in a Mouse Model of AsthmaInternational Archives of Allergy and Immunology, 2008
- Antigastritic Effect of Carbenoxolone Disodium from Glycyrrhizae RadixToxicological Research, 2007
- The Mechanism of Mineralocorticoid Action of Carbenoxolone*Endocrinology, 1982
- QUANTITATIVE AND QUALITATIVE ASPECTS OF THE PLASMA PROTEIN BINDING OF CARBENOXOLONE, AN ULCER‐HEALING DRUG*Annals of the New York Academy of Sciences, 1973